Abstract
Bradykinin is a potent activator of endothelial cells and is known to induce vasodilation, vascular permeability, and nitric oxide production. Bradykinin signaling is initiated by binding to G protein-coupled bradykinin receptors 1 and 2 (B1R and B2R). In this study we investigated whether these two receptors are involved in regulation of endothelial progenitor cell (EPC) biology. First we isolated CD34+ cells from wild-type (WT) and double B1R and B2R knockout (B1RB2R-/-) mice, and compared their capacities of proliferation, migration, as well as tube formation in a 3D cell culture system. Bone marrow-derived B1RB2R-/- EPCs displayed a reduction in proliferation and migration through collagen-coated transwell, compared with EPCs from WT mice. Moreover, implanted B1RB2R-/- EPCs into immunocompromised NOD-SCID mice showed significantly less vasculogenesis in matrigel plug. Human EPCs were isolated from peripheral blood of healthy donors using CD34+ selection. In a concentration-dependent manner, bardykinin stimulated proliferation, migration and tube formation of human EPCs. In contrast to human EPCs, human umbilicial vein endothelial cells (HUVECs) did not display a significant increase in proliferation, migration, and tube formation upon bradykinin stimulation, suggesting that bradykinin selectively enhances the function of EPCs, but not mature endothelial cells. Pre-incubation with a B2R selective antagonist (Icatibant) reduced these functions of human EPCs. When human EPCs were stimulated with [des-Arg9]-BK, a selective B1R agonist, their proliferation and tube formation remained unchanged. Moreover, preincubation of human EPCs with [des-Arg10]-Icatibant, a B1R selective antagonist, did not affect their proliferation, migration and tube formation. As detected by Western blot and real time RT-PCR, B2R was constitutively expressed in EPCs, while the expression of B1R was only induced when stimulated by inflammatory stimuli, such as TNFα and IL-1β. Take together, bradykinin regulates proliferation, migration and tube formation of EPCs through constitutively expressed B2R, whereas B1R is probably involved in inflammatory settings.
No relevant conflicts of interest to declare.
Author notes
Asterisk with author names denotes non-ASH members.
This feature is available to Subscribers Only
Sign In or Create an Account Close Modal